Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 3 2015

Print

Search Results for 'Cytovance Biologics'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Search Results:

Published January 29, 2013
Adds new bioreactors Read More »
Published January 23, 2013
Lopez to oversee Quality operations Read More »
Published May 10, 2012
Brings 20 years of leadership experience Read More »
Published March 14, 2012
Vaillant, Ernst and McDonnell join finance, operations and business development Read More »
Published April 25, 2011
Bernhard Hampl, Ph.D., has been appointed co-chairman of Cytovance Biologics, Inc. Read More »
Published April 26, 2010
Cytovance Biologics and Selexys Pharmaceutical have entered an agreement for the execution of a biopharmaceutical development and manufacturing collaboration for Anti-PSGL-1, a monoclonal antibody (mAb) being developed for treatment of inflammation associ Read More »
Published March 2, 2010
New appointments as Cytovance expands in international markets Read More »
Published August 31, 2009
Jeffrey Su, Ph.D., has been named vice president of bioanalytical development at Cytovance Read More »
Published March 28, 2008
Darren Head has been named chief executive officer of Cytovance, a bio-CMO specializing in the production of therapeutic proteins and antibodies from mammalian cell culture. Mr. Head was previously at Immucor, where he served as vice president of… Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On